Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.

By L. Sjöström, Markku Peltonen, P. Jacobson, S. Ahlin, J. Andersson-Assarsson, Åsa Anveden, C. Bouchard, B. Carlsson, K. Karason, H. Lönroth and 7 more. Journal of the American Medical Association (JAMA), 2014

1,010 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/85f309ec951fbc50ce81302b880cf73e5c9eb2df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. S. Nissen
2. A. Chait
3. K. Wolski
4. Laura J. den Hartigh
5. Gerald I. Shulman

In Surgery

1. L. Angrisani
2. J. Himpens
3. A. Chait
4. Laura J. den Hartigh
5. Gerald I. Shulman

Citations in the corpus

• Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study (2017, background): “In theSwedishObeseSubjects study, recovery fromdiabetes was found in 72%, 38%, and 30% at 2, 10, and 15 years in the surgery group, respectively.(6) By 10 years, incident diabetes (7%),hypertriglyceridemia (17%),andhypertension(41%) emerged among those in the surgical groupwho did not have these med”
• Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. (2019, background): “The conclusions reported here apply to people with type 2 diabetes diagnosed within the previous 6 years, and existing evidence has shown that remission, though still possible, is less likely after longer durations of disease.(8,10) As”
• Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019, background): “The addition of metabolic surgery (148), weight loss medications (149), and glucose-lowering agents that promote weight loss (150) can also be used as an adjunct to lifestyle interventions, resulting in greater weight loss that is maintained for a longer period of time.”
• Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (2017, background): “Severe hypoglycemia requiring intervention 0 2 (4) 0”
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “Similarly, long-term follow-up (>17 years) post-surgery in the Swedish Obesity Study showed a 32% reduction in macrovascular complications in T2DM subjects, with 29% fewer myocardial infarctions and a 29% decrease in stroke incidence (638, 639).”
• 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. (2022, background): “[116] Sjostrom L, Peltonen M, Jacobson P, et al.”
• Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers (2019, background): “PioglitazoneandvitaminE treatment of biopsy-proven nonalcoholic steatohepatitis have been shown to improve liver histology, but effects on longerterm clinical outcomes are not known (51,52).”
• Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations (2016, background): “Furthermore, evidence shows that metabolic improvement following surgery in patients with T2D correlates with shorter diabetes duration at baseline, possibly reflecting more preserved b-cell function (19,52,96).”